1. PDT IN DERMATOLOGY Rolf-Markus Szeimies M.D. Ph.D. Recklinghausen, Germany

2. PDT IN DERMATOLOGY First use in this speciality in the early 1900 surface illumination variety of indications (cancer, infection)

3. PDT IN DERMATOLOGY registered drugs since the late 90ies 5-ALA (solution, gel, patch) (for AK) 5-ALA methyl ester (ointment) for AK, init. SCC, nod. & superf. BCC no restrictions for illumination (lasers, LED, lamps, sunlight) excellent data high clearance rates favorable cosmetical results

4. WHY ISN‘T PDT A KILLER APP? light / drug combination – procedure – learning curve side effects esp. pain reimbursement issues

5. WHY ISN‘T PDT A KILLER APP? light / drug combination – procedure – learning curve side effects esp. pain reimbursement issues passed

6. WHY ISN‘T PDT A KILLER APP? light / drug combination – procedure – learning curve side effects esp. pain reimbursement issues passed

7. WHY ISN‘T PDT A KILLER APP? light / drug combination – procedure – learning curve side effects esp. pain reimbursement issues passed can this ever be solved?

8. EMERGING & NEW INDICATIONS „classical“ NMSC-PDT

9. GROWING INCIDENCE OF NON- MELANOMA SKIN CANCER © DermatologyWorld 3-15

10. EMERGING & NEW INDICATIONS „classical“ NMSC-PDT PDT and aesthetic medicine combinatoric approaches PDT and microbioma/colonization eczema, psoriasis & pilosebaceous disorders